Genética y Clínica de las Neoplasias Hematológicas y el Trasplante Hematopoyético

Hernandez-Rivas, JA; Rios-Tamayo, R; Encinas, C; Alonso, R; Lahuerta, JJ.

The changing landscape of relapsed and/or refractory multiple myeloma (MM): fundamentals and controversies

Biomarker Research. 2022; 10(1): Nº de citas: 23 [doi:10.1186/s40364-021-00344-2]

de Villambrosia, SG; Bastos, M; Palanca, JM; Cruz, JG; Navarro, JT; Tapia, G; Alonso, SA; Martin, A; Blanco, O; Abrisqueta, P; Castellvi, J; Garcia-Noblejas, A; Arranz, R; Adrados, M; Lopez, A; Montes-Moreno, S; Grp Espanol Iinfomas Trasplante GE.

BCL2 translocation in high grade B cell lymphoma (NOS, DH/TH) is associated with reduced progression free survival

LEUKEMIA & LYMPHOMA. 2022; 63(1): 101-108 Nº de citas: 5 [doi:10.1080/10428194.2021.1975189]

Rodriguez-Grande, C; Alcala, L; Estevez, A; Sola-Campoy, PJ; Buenestado-Serrano, S; Martinez-Laperche, C; de la Cueva, VM; Alonso, R; Andres-Zayas, C; Adan-Jimenez, J; Losada, C; Rico-Luna, C; Comas, I; Gonzalez-Candelas, F; Catalan, P; Munoz, P; Perez-Lago, L; de Viedma, DG; Gregorio Maranon Microbiol-ID COVI.

Systematic Genomic and Clinical Analysis of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfections and Recurrences Involving the Same Strain

EMERGING INFECTIOUS DISEASES. 2022; 28(1): 85-94 Nº de citas: 11 [doi:10.3201/eid2801.211952]

Martin-Rojas, RM; Gomez-Centurion, I; Bailen, R; Bastos, M; Diaz-Crespo, F; Carbonell, D; Correa-Rocha, R; Pion, M; Munoz, C; Sancho, M; Fernandez, IG; Oarbeascoa, G; Perez-Corral, A; Martinez-Laperche, C; Anguita, J; Buno, I; Menarguez, J; Diez-Martin, JL; Kwon, M.

Hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS) following treatment with tisagenlecleucel

Clinical Case Reports. 2022; 10(1): Nº de citas: 27 [doi:10.1002/ccr3.5209]

Zeiser, R; Socie, G; Schroeder, MA; Bhyankar, SA; Vaz, CP; Kwon, M; Clausen, J; Volodin, L; Glebel, S; Chacon, MJ; Meyers, G; Ghosh, M; Deeren, D; Sanz, J; Morariu-Zamfir, R; Arbushites, M; Lakshminarayanan, M; Barbour, AM; Chen, YB.

Efficacy and safety of itacitinib versus placebo in combination with corticosteroids for initial treatment of acute graft-versus-host disease (GRAVITAS-301) : a randomised, multicentre, double-blind, phase 3 trial

Lancet Haematology. 2022; 9(1): 14-25 Nº de citas: 15

del Rio-Garma, J; Bobillo, S; de la Rubia, J; Pascual, C; Garcia-Candel, F; Garcia-Gala, JM; Gonzalez, R; Abril, L; Vidan, J; Gomez, MJ; Pena, F; Arbona, C; Martin-Sanchez, J; Moreno, G; Romon, I; Viejo, A; Oliva, A; Linares, M; Salinas, R; Perez, S; Garcia-Erce, JA; Pereira, A; Registro Espanol Purpura; Grp Espanol Aferesis GEA.

Mortality in acquired thrombotic thrombocytopenic purpura in the pre-caplacizumab era

ANNALS OF HEMATOLOGY. 2022; 101(1): 59-67 Nº de citas: 9 [doi:10.1007/s00277-021-04685-8]

Gomez-Centurion, I; Oarbeascoa, G; Garcia, MC; Fresnena, MCL; Carreno, MJM; Vilaplana, VE; Gonzalez-Haba, E; Bailen, R; Dorado, N; Juarez, LM; Macias, GR; Lopez, PF; Encinas, C; Bastos-Oreiro, M; Anguita, J; Sanjurjo, M; Diez-Martin, JL; Kwon, M.

Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility

INTERNATIONAL JOURNAL OF HEMATOLOGY. 2022; 115(1): 61-68 Nº de citas: 11 [doi:10.1007/s12185-021-03219-2]

Duque, P; Chasco-Ganuza, M; Ortuzar, A; Almaraz, C; Terradillos, E; Perez-Rus, G; Pascual, C.

Acquired FXIII Deficiency is Associated with High Morbidity

THROMBOSIS AND HAEMOSTASIS. 2022; 122(1): 48-56 Nº de citas: 9 [doi:10.1055/a-1481-2733]

Castro-Vazquez D; Lamana A; Arribas-Castaño P; Gutiérrez-Cañas I; Villanueva-Romero R; Pérez-García S; Martínez C; Juarranz Y; Fernández de Córdoba S; González-Álvaro I; Gomariz RP; Carrión M.

The Neuropeptide VIP Limits Human Osteoclastogenesis: Clinical Associations with Bone Metabolism Markers in Patients with Early Arthritis.

Biomedicines. 2021; 9(12): [doi:10.3390/biomedicines9121880]

Alvarez-Uria, A; Escribano, P; Parra-Blanco, V; Cano-Lira, JF; Stchigel, AM; Oarbeascoa, G; Munoz, P; Guinea, J.

First Report of an Invasive Infection by Cephalotrichum gorgonifer in a Neutropenic Patient with Hematological Malignancy under Chemotherapy

Journal of Fungi. 2021; 7(12): Nº de citas: 1 [doi:10.3390/jof7121089]

Abrisqueta, P; Loscertales, J; Terol, MJ; Payer, AR; Ortiz, M; Perez, I; Cuellar-Garcia, C; de la Mata, MF; Rodriguez, A; Lario, A; Delgado, J; Godoy, A; Perez, JMA; Berruezo, MJ; Oliveira, A; Hernandez-Rivas, JA; Malo, MDG; Medina, A; Martin, PG; Osorio, S; Baltasar, P; Fernandez-Zarzoso, M; Marco, F; Mancenido, MJV; Simonovich, AS; Rubio, ML; Jarque, I; Suarez, A; Alvarez, RF; Anchel, AL; Rios, E; Castillo, MDL; Persona, EP; Munoz, RG; Ramos, R; Yanez, L; Bello, JL; Loriente, C; Acha, D; Villanueva, M.

Real-World Characteristics and Outcome of Patients Treated With Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia in Spain (IBRORS-LLC Study)

Clinical Lymphoma Myeloma & Leukemia. 2021; 21(12): 985-999 Nº de citas: 22 [doi:10.1016/j.clml.2021.07.022]

Gallego, S; Bernabeu, D; Garrido-Pontnou, M; Guillen, G; Hindi, N; Juan-Ribelles, A; Marquez, C; Mata, C; Orcajo, J; Ramirez, G; Ramos, M; Romagosa, C; Ruano, D; Rubio, P; Verges, R; Valverde, C; SEHOP Soc Espanola Hematologia Onc.

GEIS-SEHOP clinical practice guidelines for the treatment of rhabdomyosarcoma

CLINICAL & TRANSLATIONAL ONCOLOGY. 2021; 23(12): 2460-2473 Nº de citas: 9 [doi:10.1007/s12094-021-02654-1]

Steensma, DP; Wermke, M; Klimek, VM; Greenberg, PL; Font, P; Komrokji, RS; Yang, J; Brunner, AM; Carraway, HE; Ades, L; Al-Kali, A; Alonso-Dominguez, JM; Alfonso-Pierola, A; Coombs, CC; Deeg, HJ; Flinn, I; Foran, JM; Garcia-Manero, G; Maris, MB; McMasters, M; Micol, JB; De Oteyza, JP; Thol, F; Wang, ES; Watts, JM; Taylor, J; Stone, R; Gourineni, V; Marino, AJ; Yao, HL; Destenaves, B; Yuan, XB; Yu, K; Dar, S; Ohanjanian, L; Kuida, K; Xiao, JJ; Scholz, C; Gualberto, A; Platzbecker, U.

Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms

LEUKEMIA. 2021; 35(12): 3542-3550 Nº de citas: 128 [doi:10.1038/s41375-021-01328-9]

Rubio-San-Simon, A; Alvaro, RH; Ribelles, AJ; Heredia, AC; Guerra-Garcia, P; Verdu-Amoros, J; Andres, M; Canete, A; Rives, S; Perez-Martinez, A; Mora, J; Patino-Garcia, A; Lassaleta, A; Llort, A; Ramirez, M; Mata, C; Gallego, S; Martin-Broto, J; Cruz, O; La Madrid, AM; Solano, P; Romera, IM; Fernandez-Teijeiro, A; Bautista, F; Moreno, L.

The paediatric cancer clinical research landscape in Spain: a 13-year multicentre experience of the new agents group of the Spanish Society of Paediatric Haematology and Oncology (SEHOP)

CLINICAL & TRANSLATIONAL ONCOLOGY. 2021; 23(12): 2489-2496 Nº de citas: 4 [doi:10.1007/s12094-021-02649-y]

Bastos-Oreiro, M; Suarez-Gonzalez, J; Andres-Zayas, C; Carrion, NC; Moreno, S; Carbonell, D; Chicano, M; Muniz, P; Sanz, L; Diaz-Crespo, FJ; Menarguez, J; Diez-Martin, JL; Buno, I; Martinez-Laperche, C.

Incorporation of next-generation sequencing in clinical practice using solid and liquid biopsy for patients with non-Hodgkin's lymphoma

Scientific Reports. 2021; 11(1): 22815-22815 Nº de citas: 8 [doi:10.1038/s41598-021-02362-4]

Rios-Tamayo, R; Puig, N; Algarin, M; Silva, JLGD; Barbosa, N; Encinas, C; Hernandez, JA; Alonso, R; Campos, ML; Rodriguez, T; Leivas, A; Olivares, MJ; Sanchez, MJ; Paiva, B; Lahuerta, JJ; Martinez-Lopez, J.

The Current Role of the Heavy/Light Chain Assay in the Diagnosis, Prognosis and Monitoring of Multiple Myeloma: An Evidence-Based Approach

Diagnostics. 2021; 11(11): Nº de citas: 6 [doi:10.3390/diagnostics11112020]

Infante, MS; Fernandez-Cruz, A; Nunez, L; Carpio, C; Jimenez-Ubieto, A; Lopez-Jimenez, J; Vasquez, L; Del Campo, R; Romero, S; Alonso, C; Morillo, D; Prat, M; Plana, JL; Villafuerte, P; Bastidas, G; Bocanegra, A; Serna, A; De Nicolas, R; Marquet, J; Mas-Ochoa, C; Cordoba, R; Garcia-Suarez, J; Comai, A; Martin, X; Bastos-Oreiro, M; Seri, C; Navarro-Matilla, B; Lopez-Guillermo, A; Martinez-Lopez, J; Hernandez-Rivas, JA; Ruiz-Camps, I; Grande, C; GELTAMO.

Severe infections in patients with lymphoproliferative diseases treated with new targeted drugs: A multicentric real-world study

Cancer Medicine. 2021; 10(21): 7629-7640 Nº de citas: 12 [doi:10.1002/cam4.4293]

Bastos-Oreiro, M; Ortiz, J; Pradillo, V; Salas, E; Marinez-Laperche, C; Munoz, A; Buno, I; Diez-Martin, JL; Soria, JM; Izquierdo, CP.

Incorporating genetic and clinical data into the prediction of thromboembolism risk in patients with lymphoma

Cancer Medicine. 2021; 10(21): 7585-7592 Nº de citas: 8 [doi:10.1002/cam4.4280]